Cargando…

Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives

SIMPLE SUMMARY: Bladder cancer is a major global health problem. Bladder removal surgery is the standard treatment for muscle-invasive bladder cancer (25% of all bladder cancer), but this treatment negatively affects the quality of life, especially for elderly and frail patients. Tumour resection fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silina, Linda, Maksut, Fatlinda, Bernard-Pierrot, Isabelle, Radvanyi, François, Créhange, Gilles, Mégnin-Chanet, Frédérique, Verrelle, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795454/ https://www.ncbi.nlm.nih.gov/pubmed/33396795 http://dx.doi.org/10.3390/cancers13010087

Ejemplares similares

Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
por: Silina, Linda, et al.
Publicado: (2022)

The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution
por: Mégnin-Chanet, Frédérique, et al.
Publicado: (2002)

Targeting poly(ADP-ribose) polymerase activity for cancer therapy
por: Mégnin-Chanet, Frédérique, et al.
Publicado: (2010)

Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
por: Shi, Ming-Jun, et al.
Publicado: (2020)

TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
por: Dufour, Florent, et al.
Publicado: (2019)

Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery
por: Noël, Georges, et al.
Publicado: (2003)

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
por: Neuzillet, Yann, et al.
Publicado: (2017)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility
por: Godon, Camille, et al.
Publicado: (2008)

Gene List significance at-a-glance with GeneValorization
por: Brancotte, Bryan, et al.
Publicado: (2011)

Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
por: Grieco, Luca, et al.
Publicado: (2013)

Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
por: Grieco, Luca, et al.
Publicado: (2013)

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011)

Biological Effects of Scattered Versus Scanned Proton Beams on Normal Tissues in Total Body Irradiated Mice: Survival, Genotoxicity, Oxidative Stress and Inflammation
por: Chaouni, Samia, et al.
Publicado: (2020)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

Differential normal skin transcriptomic response in total body irradiated mice exposed to scattered versus scanned proton beams
por: Leduc, Alexandre, et al.
Publicado: (2021)

Publisher Correction: Differential normal skin transcriptomic response in total body irradiated mice exposed to scattered versus scanned proton beams
por: Leduc, Alexandre, et al.
Publicado: (2021)

Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases
por: Porte, Judith, et al.
Publicado: (2022)

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
por: Mahe, Mélanie, et al.
Publicado: (2018)

The impact of cyclin-dependent kinase 5 depletion on poly(ADP-ribose) polymerase activity and responses to radiation
por: Bolin, Celeste, et al.
Publicado: (2011)

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis
por: Aboudaram, Amélie, et al.
Publicado: (2023)

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
por: Reynaud, Thomas, et al.
Publicado: (2018)

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
por: Neyret-Kahn, Hélène, et al.
Publicado: (2023)

Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer
por: Kissel, Manon, et al.
Publicado: (2022)

Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein
por: Bayart, E., et al.
Publicado: (2019)

Internet of Underground Things in Agriculture 4.0: Challenges, Applications and Perspectives
por: Cariou, Christophe, et al.
Publicado: (2023)

Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma
por: Biau, Julian, et al.
Publicado: (2017)

Comment on Hunt et al, “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”
por: Yavas, Guler, et al.
Publicado: (2021)

Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”
por: Hafeez, S., et al.
Publicado: (2021)

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
por: Grapin, Mathieu, et al.
Publicado: (2019)

Oeuvre et engagement de Frédérique Joliot-Curie: A l'occasion du centième anniversaire de sa naissance
por: Joliot-Curie, Frédérique, et al.
Publicado: (2001)

Patterns of Bone Failure in Localized Prostate Cancer Previously Irradiated: The Preventive Role of External Radiotherapy on Pelvic Bone Metastases
por: Grapin, Mathieu, et al.
Publicado: (2019)

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy
por: Chevalier, Cédric, et al.
Publicado: (2016)

A prospective multicenter study on bladder cancer: the COBLAnCE cohort
por: Benhamou, Simone, et al.
Publicado: (2016)

Recurrent activating mutations of PPARγ associated with luminal bladder tumors
por: Rochel, Natacha, et al.
Publicado: (2019)

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)

Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d’Urologie
por: Sargos, Paul, et al.
Publicado: (2021)

Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study
por: Tatar, Zuzana, et al.
Publicado: (2014)

Comment on: update on the management of overactive bladder
por: Staskin, David
Publicado: (2022)

Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models
por: Biau, Julian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1a0tls14brn4i5ek2ev5t0qq4b